학술논문

Results of a randomised Phase II trial of olaparib, chemotherapy or olaparib and cediranib in patients with platinum-resistant ovarian cancer
Document Type
Article
Source
In: British Journal of Cancer. (British Journal of Cancer, 6 April 2024, 130(6):941-950)
Subject
Language
English
ISSN
15321827
00070920